
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
PRMTs and Arginine Methylation: Cancer’s Best-Kept Secret?
James Jarrold, Clare C. Davies
Trends in Molecular Medicine (2019) Vol. 25, Iss. 11, pp. 993-1009
Closed Access | Times Cited: 292
James Jarrold, Clare C. Davies
Trends in Molecular Medicine (2019) Vol. 25, Iss. 11, pp. 993-1009
Closed Access | Times Cited: 292
Showing 1-25 of 292 citing articles:
Protein arginine methylation: from enigmatic functions to therapeutic targeting
Qin Wu, Matthieu Schapira, C.H. Arrowsmith, et al.
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 7, pp. 509-530
Closed Access | Times Cited: 296
Qin Wu, Matthieu Schapira, C.H. Arrowsmith, et al.
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 7, pp. 509-530
Closed Access | Times Cited: 296
Protein arginine methyltransferases: promising targets for cancer therapy
Jee Won Hwang, Yena Cho, Gyu‐Un Bae, et al.
Experimental & Molecular Medicine (2021) Vol. 53, Iss. 5, pp. 788-808
Open Access | Times Cited: 180
Jee Won Hwang, Yena Cho, Gyu‐Un Bae, et al.
Experimental & Molecular Medicine (2021) Vol. 53, Iss. 5, pp. 788-808
Open Access | Times Cited: 180
PRMT5 function and targeting in cancer
Hyungsoo Kim, Ze’ev A. Ronai
Cell Stress (2020) Vol. 4, Iss. 8, pp. 199-215
Open Access | Times Cited: 164
Hyungsoo Kim, Ze’ev A. Ronai
Cell Stress (2020) Vol. 4, Iss. 8, pp. 199-215
Open Access | Times Cited: 164
Targeting epigenetic regulators to overcome drug resistance in cancers
Nan Wang, Ting Ma, Bin Yu
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 146
Nan Wang, Ting Ma, Bin Yu
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 146
Profiling PRMT methylome reveals roles of hnRNPA1 arginine methylation in RNA splicing and cell growth
Wenjuan Li, Yaohui He, Jingjing Yang, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 133
Wenjuan Li, Yaohui He, Jingjing Yang, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 133
Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications
Qian Zhong, Xina Xiao, Yijie Qiu, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 114
Qian Zhong, Xina Xiao, Yijie Qiu, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 114
Protein post-translational modifications in the regulation of cancer hallmarks
Haiying Wang, Liqian Yang, Minghui Liu, et al.
Cancer Gene Therapy (2022) Vol. 30, Iss. 4, pp. 529-547
Closed Access | Times Cited: 79
Haiying Wang, Liqian Yang, Minghui Liu, et al.
Cancer Gene Therapy (2022) Vol. 30, Iss. 4, pp. 529-547
Closed Access | Times Cited: 79
Protein Arginine Methyltransferase 5 (PRMT5) Inhibitors in Oncology Clinical Trials: A review
Kavanya Feustel, Gerald S. Falchook
Journal of Immunotherapy and Precision Oncology (2022) Vol. 5, Iss. 3, pp. 58-67
Open Access | Times Cited: 77
Kavanya Feustel, Gerald S. Falchook
Journal of Immunotherapy and Precision Oncology (2022) Vol. 5, Iss. 3, pp. 58-67
Open Access | Times Cited: 77
PHGDH arginine methylation by PRMT1 promotes serine synthesis and represents a therapeutic vulnerability in hepatocellular carcinoma
Kui Wang, Li Luo, Shuyue Fu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 58
Kui Wang, Li Luo, Shuyue Fu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 58
PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer
Chang‐Ching Lin, Tsung-Cheng Chang, Yunguan Wang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 16
Chang‐Ching Lin, Tsung-Cheng Chang, Yunguan Wang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 16
Methylation of EZH2 by PRMT1 regulates its stability and promotes breast cancer metastasis
Zhongwei Li, Diandian Wang, Jun Lü, et al.
Cell Death and Differentiation (2020) Vol. 27, Iss. 12, pp. 3226-3242
Open Access | Times Cited: 126
Zhongwei Li, Diandian Wang, Jun Lü, et al.
Cell Death and Differentiation (2020) Vol. 27, Iss. 12, pp. 3226-3242
Open Access | Times Cited: 126
Foxp3 Post-translational Modifications and Treg Suppressive Activity
Guoping Deng, Xiaomin Song, Shigeyoshi Fujimoto, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 123
Guoping Deng, Xiaomin Song, Shigeyoshi Fujimoto, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 123
PRMT6 methylation of RCC1 regulates mitosis, tumorigenicity, and radiation response of glioblastoma stem cells
Tianzhi Huang, Yongyong Yang, Xiao Song, et al.
Molecular Cell (2021) Vol. 81, Iss. 6, pp. 1276-1291.e9
Open Access | Times Cited: 86
Tianzhi Huang, Yongyong Yang, Xiao Song, et al.
Molecular Cell (2021) Vol. 81, Iss. 6, pp. 1276-1291.e9
Open Access | Times Cited: 86
CARM1/PRMT4: Making Its Mark beyond Its Function as a Transcriptional Coactivator
Samyuktha Suresh, S. Huard, Thierry Dubois
Trends in Cell Biology (2021) Vol. 31, Iss. 5, pp. 402-417
Closed Access | Times Cited: 77
Samyuktha Suresh, S. Huard, Thierry Dubois
Trends in Cell Biology (2021) Vol. 31, Iss. 5, pp. 402-417
Closed Access | Times Cited: 77
Arginine methylation of SARS-Cov-2 nucleocapsid protein regulates RNA binding, its ability to suppress stress granule formation, and viral replication
Ting Cai, Zhenbao Yu, Zhen Wang, et al.
Journal of Biological Chemistry (2021) Vol. 297, Iss. 1, pp. 100821-100821
Open Access | Times Cited: 67
Ting Cai, Zhenbao Yu, Zhen Wang, et al.
Journal of Biological Chemistry (2021) Vol. 297, Iss. 1, pp. 100821-100821
Open Access | Times Cited: 67
Protein arginine methyltransferase 3 promotes glycolysis and hepatocellular carcinoma growth by enhancing arginine methylation of lactate dehydrogenase A
Lei Yu, Ping Han, Yu Chen, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 56
Lei Yu, Ping Han, Yu Chen, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 56
DNA Repair and Therapeutic Strategies in Cancer Stem Cells
Matthew S. Gillespie, Ciara Ward, Clare C. Davies
Cancers (2023) Vol. 15, Iss. 6, pp. 1897-1897
Open Access | Times Cited: 40
Matthew S. Gillespie, Ciara Ward, Clare C. Davies
Cancers (2023) Vol. 15, Iss. 6, pp. 1897-1897
Open Access | Times Cited: 40
Proteomics of post-translational modifications in colorectal cancer: Discovery of new biomarkers
Gengjun Zhu, Lifang Jin, Wanchun Sun, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 4, pp. 188735-188735
Closed Access | Times Cited: 39
Gengjun Zhu, Lifang Jin, Wanchun Sun, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 4, pp. 188735-188735
Closed Access | Times Cited: 39
A global view of the human post-translational modification landscape
Naoya Kitamura, James J. Galligan
Biochemical Journal (2023) Vol. 480, Iss. 16, pp. 1241-1265
Open Access | Times Cited: 35
Naoya Kitamura, James J. Galligan
Biochemical Journal (2023) Vol. 480, Iss. 16, pp. 1241-1265
Open Access | Times Cited: 35
PRMT3‐Mediated Arginine Methylation of METTL14 Promotes Malignant Progression and Treatment Resistance in Endometrial Carcinoma
Yiru Wang, Can Wang, Xue Guan, et al.
Advanced Science (2023) Vol. 10, Iss. 36
Open Access | Times Cited: 32
Yiru Wang, Can Wang, Xue Guan, et al.
Advanced Science (2023) Vol. 10, Iss. 36
Open Access | Times Cited: 32
PRMT5 methylating SMAD4 activates TGF-β signaling and promotes colorectal cancer metastasis
Anyi Liu, Chengxin Yu, Cheng Qiu, et al.
Oncogene (2023) Vol. 42, Iss. 19, pp. 1572-1584
Open Access | Times Cited: 31
Anyi Liu, Chengxin Yu, Cheng Qiu, et al.
Oncogene (2023) Vol. 42, Iss. 19, pp. 1572-1584
Open Access | Times Cited: 31
PRMT1 inhibition promotes ferroptosis sensitivity via ACSL1 upregulation in acute myeloid leukemia
Lixin Zhou, Xiaoqing Jia, Yingying Shang, et al.
Molecular Carcinogenesis (2023) Vol. 62, Iss. 8, pp. 1119-1135
Closed Access | Times Cited: 26
Lixin Zhou, Xiaoqing Jia, Yingying Shang, et al.
Molecular Carcinogenesis (2023) Vol. 62, Iss. 8, pp. 1119-1135
Closed Access | Times Cited: 26
Overview of epigenetic degraders based on PROTAC, molecular glue, and hydrophobic tagging technologies
Xiaopeng Peng, Zhihao Hu, Limei Zeng, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 2, pp. 533-578
Open Access | Times Cited: 25
Xiaopeng Peng, Zhihao Hu, Limei Zeng, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 2, pp. 533-578
Open Access | Times Cited: 25
The functions and mechanisms of post-translational modification in protein regulators of RNA methylation: Current status and future perspectives
Youming Chen, Zuli Jiang, Ying Yang, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 126773-126773
Closed Access | Times Cited: 23
Youming Chen, Zuli Jiang, Ying Yang, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 126773-126773
Closed Access | Times Cited: 23
Promising role of protein arginine methyltransferases in overcoming anti-cancer drug resistance
Yongxia Zhu, Tong Xia, D Chen, et al.
Drug Resistance Updates (2023) Vol. 72, pp. 101016-101016
Open Access | Times Cited: 23
Yongxia Zhu, Tong Xia, D Chen, et al.
Drug Resistance Updates (2023) Vol. 72, pp. 101016-101016
Open Access | Times Cited: 23